NO971875L - Cathepsin 02 protease - Google Patents

Cathepsin 02 protease

Info

Publication number
NO971875L
NO971875L NO971875A NO971875A NO971875L NO 971875 L NO971875 L NO 971875L NO 971875 A NO971875 A NO 971875A NO 971875 A NO971875 A NO 971875A NO 971875 L NO971875 L NO 971875L
Authority
NO
Norway
Prior art keywords
cathepsin
protease
antibodies
proteins
relates
Prior art date
Application number
NO971875A
Other languages
English (en)
Other versions
NO971875D0 (no
Inventor
Dieter Broemme
Kathleen Okamoto
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26987129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO971875(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/330,121 external-priority patent/US5736357A/en
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of NO971875D0 publication Critical patent/NO971875D0/no
Publication of NO971875L publication Critical patent/NO971875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO971875A 1994-10-27 1997-04-23 Cathepsin 02 protease NO971875L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/330,121 US5736357A (en) 1994-10-27 1994-10-27 Cathespin O protease
US08/536,861 US6544767B1 (en) 1994-10-27 1995-10-02 Cathespin O2 protease
PCT/US1995/013820 WO1996013523A1 (en) 1994-10-27 1995-10-26 Cathepsin o2 protease

Publications (2)

Publication Number Publication Date
NO971875D0 NO971875D0 (no) 1997-04-23
NO971875L true NO971875L (no) 1997-06-12

Family

ID=26987129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971875A NO971875L (no) 1994-10-27 1997-04-23 Cathepsin 02 protease

Country Status (15)

Country Link
US (2) US6544767B1 (no)
EP (1) EP0783527B1 (no)
JP (1) JP3670666B2 (no)
KR (1) KR100473219B1 (no)
CN (1) CN1148382C (no)
AT (1) ATE317441T1 (no)
AU (1) AU711810B2 (no)
CA (1) CA2203765C (no)
DE (1) DE69534778T2 (no)
ES (1) ES2256849T3 (no)
FI (1) FI971777A7 (no)
HU (1) HU220960B1 (no)
NO (1) NO971875L (no)
NZ (1) NZ296003A (no)
WO (1) WO1996013523A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403304B1 (en) 1993-04-06 2002-06-11 Forsyth Dental Infirmary For Children Human osteoclast-specific and -related DNA sequences
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
SK56798A3 (en) * 1995-10-30 1998-12-02 Smithkline Beecham Corp Protease inhibitors, pharmaceutical composition containing them and their use
US6586466B2 (en) 1995-10-30 2003-07-01 Smithkline Beecham Corporation Carbohydrazide-protease inhibitors
HUP9802488A3 (en) 1995-10-30 2001-10-29 Smithkline Beecham Corp Method of inhibiting cathepsin k
EP0812916A3 (en) * 1996-06-14 1998-12-09 Smithkline Beecham Corporation Cathepsin k gene
AU3802297A (en) * 1996-07-03 1998-01-21 Novadx, Inc. Method for detecting degenerative bone disease
GB9701888D0 (en) * 1997-01-30 1997-03-19 Ciba Geigy Ag Novel methods
US5948669A (en) * 1997-02-26 1999-09-07 Smithkline Beecham Corporation Rat cathepsin K polynucleotide and polypeptide sequence
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6346373B1 (en) * 1999-05-05 2002-02-12 Merck Frosst Canada & Co., Whole cell assay for cathepsin K activity
AU6199100A (en) * 1999-06-25 2001-01-31 Hybritech Incorporated Cloning and expressing of human cathepsin k in mammalian cells
JP2003513971A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
EP1229914A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
CA2397194C (en) 2000-01-20 2011-05-17 Mark E. Duggan Alpha v integrin receptor antagonists
KR20020082896A (ko) 2000-03-21 2002-10-31 스미스클라인 비참 코포레이션 프로테아제 억제제
AU2002239753A1 (en) * 2000-10-18 2002-05-21 Incyte Genomics, Inc. Proteases
CN100408681C (zh) * 2002-06-17 2008-08-06 株式会社日冷 来源于粉红色虾的新型组织蛋白酶l样半胱氨酸蛋白酶
AU2003256305A1 (en) * 2002-06-24 2004-01-06 Axys Pharmaceuticals, Inc. Peptidic compounds as cysteine protease inhibitors
TW200510436A (en) * 2003-07-21 2005-03-16 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
AU2004266740B2 (en) 2003-08-21 2010-08-26 Merck Frosst Canada Ltd Cathepsin cysteine protease inhibitors
US20070015234A1 (en) * 2003-09-23 2007-01-18 Sylvie Desmarais Whole cell assay for inhibitors of cathepsin k
WO2005093421A1 (de) * 2004-03-10 2005-10-06 Biovendor Laboratory Medicine, Inc. Enzymimmunoassay zur bestimmung von cathepsin k
US7029902B2 (en) * 2004-03-26 2006-04-18 Applera Corporation Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2013202011C1 (en) * 2008-03-06 2015-10-01 Halozyme, Inc. In vivo temporal control of activatable matrix-degrading enzymes
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US8901144B2 (en) 2013-02-07 2014-12-02 Scifluor Life Sciences, Llc Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
HRP20171873T1 (hr) 2013-02-07 2018-02-23 Scifluor Life Sciences, Inc Fluorinirani antagonisti integrina
SG11201609050UA (en) 2014-05-30 2016-12-29 Pfizer Carbonitrile derivatives as selective androgen receptor modulators
KR102647026B1 (ko) 2015-02-19 2024-03-12 사이플루어 라이프 사이언시즈, 인크 플루오르화 테트라히드로나프티리디닐 노난산 유도체 및 이의 용도
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
AU6333296A (en) 1996-06-14 1998-01-07 Human Genome Sciences, Inc. Cathepsin k gene

Also Published As

Publication number Publication date
NO971875D0 (no) 1997-04-23
ES2256849T3 (es) 2006-07-16
KR100473219B1 (ko) 2005-05-16
US20030175937A1 (en) 2003-09-18
FI971777L (fi) 1997-04-25
FI971777A0 (fi) 1997-04-25
DE69534778T2 (de) 2006-08-17
CN1170415A (zh) 1998-01-14
EP0783527A1 (en) 1997-07-16
AU3968895A (en) 1996-05-23
AU711810B2 (en) 1999-10-21
HUT77049A (hu) 1998-03-02
WO1996013523A1 (en) 1996-05-09
DE69534778D1 (en) 2006-04-20
FI971777A7 (fi) 1997-04-25
JPH10512740A (ja) 1998-12-08
KR970707153A (ko) 1997-12-01
CN1148382C (zh) 2004-05-05
EP0783527A4 (en) 1998-12-02
ATE317441T1 (de) 2006-02-15
EP0783527B1 (en) 2006-02-08
CA2203765C (en) 2002-04-23
NZ296003A (en) 1999-10-28
CA2203765A1 (en) 1996-05-09
HU220960B1 (hu) 2002-07-29
JP3670666B2 (ja) 2005-07-13
US6544767B1 (en) 2003-04-08

Similar Documents

Publication Publication Date Title
NO971875D0 (no) Cathepsin 02 protease
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
TR199600357A2 (tr) Rekombinant simanlik (Ob) proteinleri.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
FI905003L (fi) Glykosaminoglykan modifierat protein.
DE69839444D1 (de) Smad 6 und dessen anwendungen
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
ATE360695T1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
TR199500915A2 (tr) Peptidler.
EP0758891A4 (en) HALOMETHYLAMIDES AS IL-1 BETA PROTEASE INHIBITORS
ATE285474T1 (de) Haemophilus adhäsionsproteinen
DE69007556D1 (de) Protein-Hydrolyse.
SE9602822D0 (sv) New receptor
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
TR199501328A2 (tr) Alzheimer peptidi.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
FI904357A0 (fi) Foerfarande foer aktivering av protein c.
EP0804556A4 (en) PROTEIN MODIFYING ENZYME
NO975534L (no) Imidazo-£1,5|-pyridin-avledete serinproteaseinhibitorer
SE9604439D0 (sv) New receptor
NL1000131C2 (nl) Monomere en oligomere bisfenyl-HALS-fosfieten als stabiliseermiddelen.
MX9203129A (es) Proteinas bmp-5.
MX9203296A (es) Proteinas bmp-7.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application